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PHYSIOLOGY BASED TOXICOKINETIC MODELLING (PBTK) 
CYP activities in human liver 
A cursory literature search for CYP 450 activity in liver was run in TOXLINE 
(https://toxnet.nlm.nih.gov/newtoxnet/toxline.htm) searching for “CYP”, “human”, “liver”, 
“Vmax” and “Km”. Data found are summarized in Table A1.  
 
Table A1: Data for human hepatic metabolism (CYP) for some VOC  
Substrate Vmax [M/h] Km [M] 
Chlorzoxazona) 7.43E-04 2.75E-04 
p-Nitrophenola) 1.54E-04 1.29E-04 
Vinylfluorideb) 4.11E-05 4.35E-07 
Acetonc) 1.49E-05 8.60E-07 
Styrened)  2.00E-03 1.00E-05 
Pyrenee) 3.60E-04 4.50E-06 
tert-Butyl-methylethere) 5.00E-04 5.00E-05 
n-Heptanee) 1.40E-02 1.10E-03 
Trichloro-ethylenef) 3.38E-05 1.33E-05 
Acrylonitrileg) 6.24E-04 1.55E-05 
Chloroformh) 1.29E-04 3.50E-06 
Toluenei) 5.22E-05 5.98E-06 
Ethylbenzenei) 6.89E-05 1.29E-05 
Xylenei) 5.19E-05 2.08E-06 
Benzenej) 2.04E-04 4.49E-06 
a): Hanioka et al. (2003); b): Cantoreggi and Kellner (1997); c): Kumagai and Matsunaga (1995); d): Csanady et al. (1994, 2003); 
e): Jongeneelen and ten Berge (2011); f): Fisher (2000); g): Kedderis et al. (1993); h): Webster et al. (2016); i): Tardif et al. (1997); 
j): Travis et al. (1990);     
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At low VOC concentrations the Michaelis-Menten kinetic is expected to be first order, as 
expressed by the ratio Vmax / Km, which is a first order reaction rate constant. The difference 
in this reaction rate for CYP metabolism (Vmax/Km), according to Table 1, is up to 168. For 
the read across between substances based on the PBTK model IndusChemFate v2.1, the me-
dian was used for Vmax and Km (Table A2).  
 
Table A2: Quartiles for human hepatic CYP metabolism in the PBTK modelling 
Quartile  Vmax [M/h] Km [M] 
1st  5.22E-05 5.98E-06
2nd (median) 1.54E-04 1.00E-05
3rd  6.24E-04 1.55E-05
 
For read across purposes it is generally accepted that the toxic action of a compound is 
driven by its concentration over time in the target organ – the toxicokinetic factor – and its 
specific interaction with the target tissue – the toxicodynamic factor. The toxicokinetic factor 
can be addressed by PBTK modelling. If specific data for a substance are missing it is always 
critical what is the right assumption for a metabolic turnover. In this work, it is assumed that 
the target compound and its reference compound are not different against CYP 450 mediated 
reactions. However, to demonstrate potential critical issues it is assumed that the target com-
pound may show a CYP 450 mediated turnover at the third quartile and the reference com-
pound having an activity at the first quartile, or vice versa, whatever would represent the 
worst case. 
 
Propenyloxypropanol (Allyloxypropanol, AOP) 
Table A3 below summarizes the physical properties of allyloxypropanols against their 
read across candidate 2,2-Bis(allyloxy)-2-ethyl-butanol-1- (BAB). These physical data were 
used to run a PBPK modelling with the free software IndusChemFate v2.0 (Jongeneelen and 
ten Berge, 2011). The concentration in air was set to 1 mg/m³, and 28 day non-stop exposure 
of a man of 70 kg body weight was modelled. In absence of data, enterohepatic circulation 
was set to zero and renal re-absorption was set to “unknown”. First, concentrations of the re-
spective parent compounds were calculated, assuming an equivalent turnover by phase I me-
tabolism. The assumed CYP 450 activities are given in Table A2. 
 
Table A3: Physical chemical data of AOPs and structural analogues 
Substance CAS-No. Vapor  
pressure 
Water  
solubility 
Log Kow Density/  
20 °C 
Mol-wt.
1-(Allyloxy)-2- 
propanol 
21460-36-6 103 Pa / 
25 °Ca) 
166… 265 g/La) 0.36a) 0.991b) 132.2 
2-(Allyloxy)-1- 
propanol 
1331-17-5 103 Pa / 
25 °Ca) 
166…265 g/La) 0.36a) 0.991b) 132.2 
2,2-
Bis(allyloxymethyl) 
butan-1-ol 
682-09-7 0.17…0.23 / 
25 °Cc) 
4.1 g/L 3.0c) 0.96c) 214.3 
a): calculated with EPISUITE v4.1, EPA (2017);  b): calculated with ChemSketch; c): BAB (2018) 
 
If for both compounds, BAB and AOP, the same metabolic turnover in liver is assumed, 
nearly identical steady state concentrations will be achieved in this organ (Figure A1). How-
ever, if BAB is degraded by a rate equivalent to the 3rd quartile of the CYP activity, but AOP 
is transformed at a 1st quartile rate, only, a five fold smaller air concentration of AOP is re-
quired to achieve equal steady state levels in human liver (Figure A2).  
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Figure A1: Liver concentration [µmol/L] for Vmax = 1.54 x 10-4 mol/h/kg and Km = 10-5 mol/L for BAB 
(rhombus) and AOP (triangle) for continuous air exposure against 1 mg/m³ 
 
 
Figure A2: Liver concentration [µmol/L]; BAB (rhombus): Cair = 1.0 mg/m³,  Vmax = 6.24 x 10-4 mol/h/kg 
and Km = 1.6 x 10-5 mol/L; AOP (triangles): Cair = 0.2 mg/m³,  Vmax = 5.22 x 10-5 mol/h/kg and Km = 5.98 
x 10-6 mol/L 
 
The phase I metabolism may create epoxides, which can add to biological macromole-
cules and, therefore, epoxidation is a toxicification. Phase II metabolism may detoxify the 
epoxides, namely due to hydrolysis catalyzed by epoxyhydrolase (EH) and due to addition of 
glutathione (GSH), mediated by glutathione-S-transferase (GST).  
Enzymatic parameters for these phase II metabolism steps are published by Csanady et al. 
(1994, 2003) and are summarized in Table A4. The initial concentrations of GSH in liver and 
lung are 5.9 and 2.0 mM, respectively, and the zero order production rates of GSH in liver 
and lung are 0.9 and 0.3 mM/h, respectively.  
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Table A4: Enzyme parameters for human lung and liver epoxyhydrolase and glutathione-S-
transferase (Csanady et al., 1994, 2003). 
 Vmax [M/h] Km,S [M] Km,GSH [M]
GST lung 8.2E-02 2.5E-03 1.0E-04 
GST liver 2.8E-02 2.5E-03 1.0E-04 
EH lung 6.7E-04 1.8E-05 ---- 
EH liver 4.5E-03 1.0E-05 ---- 
 
Epoxide hydrolysis and addition of GSH to epoxides are parallel reactions, both mitigat-
ing the epoxide. While the action of epoxide hydrolase can be modelled by simple Michaelis-
Menten kinetics, the reaction with glutathione is a bi-substrate reaction with a more compli-
cated rate expression. The decay rate of epoxide is the sum of both reaction rates and can be 
expressed as  
 
െݒ ൌ ௏೘ೌೣ,ಶಹ	ൈ	ሾௌሿ௄೘,ಶಹାሾௌሿ ൅ 
௏೘ೌೣ,ಸೄ೅ൈሾீௌுሿൈሾௌሿ
௄೘,ಸೄ೅,ೄሾீௌுሿା௄೘,ಸೄ೅,ಸೄಹሾௌሿାሾௌሿሾீௌுሿ 
 
(Csanady et al., 1994, 2003). The first term on the right hand side describes the epoxide decay 
catalyzed by epoxide hydrolase, whereas the second term describes the epoxide reaction with 
glutathione. This expression is too complicated to introduce it into the convenient In-
dusChemFate program. However, a few approximations can be introduced. One approxima-
tion is the assumption, that GST and GSH don’t play a role (worst case), and only epoxide 
hydrolase serves for the decay of epoxide. The other assumption is that the epoxide concen-
tration is always that low, that the concentration of GSH is not changed and maintained at 2.0 
mM in the lung and 5.9 mM in the liver (Csanady et al., 2003). At such conditions it can be 
assumed that Km is much larger than the substrate concentration, and the following simplifica-
tions are introduced: 
 
െݒ ൌ ௠ܸ௔௫,ாு 	ൈ	 ሾܵሿܭ௠,ாு ൅ ሾܵሿ ൅	
௠ܸ௔௫,ீௌ் ൈ ሾܩܵܪሿ଴ ൈ ሾܵሿ
ܭ௠,ீௌ்,ௌ ൈ ሾܩܵܪሿ଴ ൅ ܭ௠,ீௌ்,ீௌு ൈ ሾܵሿ ൅ ሾܵሿ ൈ ሾܩܵܪሿ଴
  
 
െݒ ൎ ௠ܸ௔௫,ாு 	ൈ	 ሾܵሿܭ௠,ாு ൅
௠ܸ௔௫,ீௌ் ൈ ሾܩܵܪሿ଴ ൈ ሾܵሿ
ܭ௠,ீௌ்,ௌ ൈ ሾܩܵܪሿ଴ ൅ ሼܭ௠,ீௌ்,ீௌு ൅ ሾܩܵܪሿ଴ሽ ൈ ሾܵሿ 
 
െݒ ൎ ሼ ௠ܸ௔௫,ாு	ܭ௠,ீௌ்,ௌ ൅ ௠ܸ௔௫,ீௌ்ܭ௠,ாுሽ ൈ ሾܩܵܪሿ଴ ൈ ሾܵሿܭ௠,ாுܭ௠,ீௌ்,ௌሾܩܵܪሿ଴ ൅ ܭ௠,ாு൛ܭ௠,ீௌ்,ீௌு ൅ ሾܩܵܪሿ଴ൟ ൈ ሾܵሿ ൅ 
௠ܸ௔௫,ாு ൈ ሼܭ௠,ீௌ்,ீௌு ൅ ሾܩܵܪሿ଴ሽ ൈ ሾܵሿଶ
ܭ௠,ாுܭ௠,ீௌ்,ௌሾܩܵܪሿ଴ ൅ ܭ௠,ாு൛ܭ௠,ீௌ்,ீௌு ൅ ሾܩܵܪሿ଴ൟ ൈ ሾܵሿ 
 
As the second term contains [S]² while [S] is assumed to be very small, the second term is 
expected to be much smaller than the first term and, therefore, omitted: 
 
െݒ ൎ ሼ ௠ܸ௔௫,ாு	ܭ௠,ீௌ்,ௌ ൅ ௠ܸ௔௫,ீௌ்ܭ௠,ாுሽ ൈ ሾܩܵܪሿ଴ ൈ ሾܵሿܭ௠,ாுܭ௠,ீௌ்,ௌሾܩܵܪሿ଴ ൅ ܭ௠,ாு൛ܭ௠,ீௌ்,ீௌு ൅ ሾܩܵܪሿ଴ൟ ൈ ሾܵሿ 
Now, the following new constants are introduced, 
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௠ܸ௔௫# ൌ 	 ሼ ௠ܸ௔௫,ாு	ܭ௠,ீௌ்,ௌ ൅ ௠ܸ௔௫,ீௌ்ܭ௠,ாுሽ ൈ ሾܩܵܪሿ଴ܭ௠,ாு൛ܭ௠,ீௌ்,ீௌு ൅ ሾܩܵܪሿ଴ൟ  
ܭ௠# ൌ ܭ௠,ாுܭ௠,ீௌ்,ௌሾܩܵܪሿ଴ܭ௠,ாு൛ܭ௠,ீௌ்,ீௌு ൅ ሾܩܵܪሿ଴ൟ 
which results in the rate equation 
െݒ ൌ ௠ܸ௔௫
# ൈ ሾܵሿ
ܭ௠# ൅ ሾܵሿ  
Vmax# and Km# can be introduced in the IndusChemFate model, and with respect to the dif-
ferent organs, the values are  
for the liver:  
Vmax# = 1.134 mol/kg/h, 
Km#  = 2.46 x 10-3 mol/L, 
and for the lung: 
Vmax# = 1.67 x 10-1 mol/kg/h, 
Km# =  2.38 x 10-3 mol/L. 
At this point, it is assumed that phase I metabolism is a toxification reaction, whereas 
phase II metabolism is a detoxification. The steady state concentration of the epoxide follow-
ing continuous air exposure shall be modelled. Table A5 lists the calculated physico-chemical 
parameters for the allyloxypropanol (AOP) oxidation product, the Glycidyl-(2-
hydroxy)propyl ether (AOP epoxide), and for the 2,2-Bis(Allyloxymethyl)-2-ethyl-butanol-1 
(BAB) epoxidation product, the 2-Allyloxymethyl-2-glycidyloxymethyl-2ethyl-butanol-1 
(BAB epoxide).  As worst case it is assumed that epoxidation of BAB is slow (1st quartile for 
CYP activity in liver) and AOP epoxidation is fast (3rd quartile CYP acitivity in liver).  
 
 
Table A5: Physico-chemical data and enzymatic data taken forward for PBTK modelling 
Substance Vmax [M/h] Km [M] Vapor 
pressure 
Water  
solubility 
Log 
Kow 
Density 
/ 20 °C 
Mol- 
wt. 
Allyloxy- 
propanol 
6.24E-04 
(CYP, liver); 
2.50E-06 
(CYP, lung) 
15.5 (liver); 
17.5 (lung) 
103 Pa / 
25 °Ca) 
166…265 
g/La) 
0.36a) 0.991b) 116.2 
AOP epoxide 4.50E-03 
(EH); 1.134 
(EH + GST) 
10 (EH); 
2460 (EH + 
GST) 
16.2 / 
25 °Ca) 
> 100 g/La) -
0.95a) 
1.16b) 132.2 
2,2-
Bis(allyloxym
ethyl)-butan-
1-ol (BAB) 
5.20E-05 
(CYP, liver); 
2.50E-06 
(CYP, lung) 
6 (liver); 
17.5 (lung) 
0.17…0.2
3 / 25 °Cc) 
4.1 g/L 3.0c) 0.96c) 214.3 
BAB epoxide 4.50E-03 
(EH); 1.134 
(EH + GST) 
10 (EH); 
2460 (EH + 
GST) 
0.0025a) 32.2 g/La) 0.57a) 1.05b) 230.3 
a): calculated with EPISUITE v4.1, EPA (2017);  b): calculated with ChemSketch v2017.1; c): BAB (2018) 
 
For the AOP epoxide and BAB epoxide, Vmax# and Km# for liver and lung are introduced 
in the model, and calculations are run under assumption of constant GSH concentrations. 
However, the level of GSH may become exhausted, which would finally end up in some cell 
damage and would not be in concordance with a NOAEL. However, as this exercise is a read 
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across from BAB to AOP, the model is run also under assumption that only epoxide hydrolase 
serves for the decay of epoxides. Results are shown in Table A6. Naturally, the slower phase I 
metabolism of BAB compared to AOP results in about five fold higher levels in the liver; de-
cay of the epoxides by EH alone or by EH and GST in combination leads to nearly equivalent 
levels of epoxides of AOP and BAB, respectively.  
 
 
Table A6: Levels of BAB and AOP and their epoxides in human liver (µmol/L) after continuous expo-
sure against 1 mg/m² 
 BAB AOP BAB 
epoxide 
AOP 
epoxide 
EH activity only 9.89 
E-01 
2.06 
E-01 
1.61 
E-02 
1.70 
E-02 
EH and GST activity 9.89 
E-01 
2.06 
E-01 
1.59 
E-03 
1.71 
E-03 
 
As can be seen in Figure A3, also for the epoxide metabolites BAB takes some more time 
to achieve the stady state in the liver. In case of GST and EH activity, steady state levels of 
epoxides in the liver are a factor of about 10 lower when compared to only EH activity. The 
higher epoxidation rate of AOP against BAB on the one hand causes a five fold lower concen-
tration of the parent compound in the liver, on the other hand a higher concentration of the 
epoxide in the liver. However, AOP epoxide levels are only 5 to 7 % higher than BAB epox-
ide levels.  
 
 
Figure A3: Concentration (µmol/L) of BAB epoxide (squares) and AOP epoxide (circles) depending on 
EH activity alone (filled symbols) and combined EH and GST activity (empty symbols) 
 
 
2,3-Diethyl-2,3-dimethy-succinodinitrile (DEDMSD) 
For 2,3-diethyl-2,3-dimethyl-succinodinitrile, DEDMSD, two CAS-numbers are availa-
ble: 128903-20-8 and 85688-81-9. Substance specific toxicological data for DEDMSD were 
not identified. For read across, data for aliphatic tertiary nitriles were searched. 2,2,3,3,-
tetramethyl succino dinitrile (TMSD, CAS-No. 3333-52-6) and 2,2,4-trimethyl-4-phenyl-
butane nitrile (TMPBN, CAS-No. 75490-39-0) were detected as structural analogues with re-
peated dose toxicity data (TMPBN, 2018). To focus the read across on tertiary nitriles is justi-
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fied as primary and secondary nitriles may undergo alpha-hydroxylation; the resulting cyano-
hydrins can easily release cyanide ions, which is not the case for the tertiary nitriles. For ex-
ample, sodium thiosulfate as a sulfur depot for detoxification of cyanide was protective for in-
toxication with adiponitrile by supporting the conversion of cyanide to thiocyanate, but for 
TMSD it was without any effect (Doherty et al., 1982). 
Both succinodinitriles were compared on the basis of physiology based toxicokinetic 
modelling. With these data, the blood concentration of the substances in man for continuous 
exposure against 1 mg/m³ was calculated with the program IndusChemFate v2.0 (Jongeneelen 
and ten Berge, 2011). Data are shown in Table A7. Based on the calculated results, the toxi-
cokinetic difference between TMSD and DEDMSD is far less than a factor of 2 in typical 
VOC target organs brain, liver and kidneys.  
Again, it may be assumed that the CYP 450 metabolism of TMSD is fast (3rd quartile, Ta-
ble A2) and that of DEDMSD is slow (1st quartile, Table A2). Figure A4 shows the concentra-
tion in the target organ liver in dependence on exposure time; Figure A5 shows the concentra-
tion-time curve for the target organ kidney.  
 
 
Table A7: Physico-chemical and enzyme kinetic data for tetramethyl succinodinitrile (TMSD) and 2,3-
diethyl-2,3-dimethyl-succinodinitrile (DEDMSD) 
 TMSD DEDMSD
Molar mass 136 g/mol 164 g/mol 
Melting pointa) 170 °C (exp.) 56 °C 
Water solubilitya) 5320 mg/L 3661 mg/L 
Vapour pressure / 25 °Ca) 4.9 Pa 0.85 Pa 
log Kowa) 1.1 2.1 
densityb) 0.923 g/cm³ 0.910 g/cm³ 
Vmax liver (CYP) 1.54E-04 mol/kg/h 1.54E-04 mol/kg/h 
Km liver (CYP) 1.00E-05 mol/L 1.00E-05 mol/L 
Vmax lung (CYP) 2.50E-06 2.50E-06 
Km lung (CYP) 1.75E-05 1.75E-05 
a): calculated with EPISUITE v4.1, EPA (2017);  b): calculated with ChemSketch 
 
 
Table A8: Calculated steady state concentrations [µmol/L] of TMSD and DEDMSD in different tissues 
following continuous exposure against 1 mg/m³ 
 TMSD DEDMSD 
Venous blood 0.726 0.407 
Liver 0.554 0.672 
Kidney 0.735 0.659 
Brain 0.912 0.918 
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Figure A4: Liver concentration (µmol/L):  TMDS at median (rhombus) or 3rd quartile (triangle) CYP ac-
tivity; DEDMSD at median (squares) and 1st quartile (circles) CYP activity 
 
 
Figure A5: Steady state kidney concentration (µmol/L) of TMSD (squares; CYP 3rd = quartile) and 
DEDMSD (rhombus, CYP = 1st quartile) 
 
 
Therefore, if the turnover of TMSD in liver is high (3rd quartile) and that of DEDMSD is 
low (1st quartile), an air concentration of 0.18 mg/m³ DEDMSD would result in an equivalent 
steady state liver and kidney concentrations as 1 mg/m³ TMSD.  
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METBOLITE PREDICTIONS  
Metabolites were predicted with help of the OECD QSAR Toolbox (2018), version 4.2, 
with the rat in vivo metabolism simulator. 
 
Metabolites of Allyloxypropanol
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Metabolites of 2,2-Bis(allyloxymethyl)-butan-1-ol (BAB) 
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Metabolites of 2,3-diethyl-2,3-dimethyl-succinodinitrile (DEDMSD) 
 
In vivo rat metabolism simulator results: 
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Metabolites of 2,2,3,3-tetramethyl-succinodinitrile (TMSD) 
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